Cancer diagnoses are expected to exceed 2 million annually in the United States, increasing laboratory volumes and the complexity of pathology workups.
2
Earlier detection may bring more subtle or borderline lesions into the diagnostic pathway, requiring pathologists to integrate morphology, molecular profiling, germline testing, and other findings.
3
Laboratories should design workflows alongside new tests, including automation, digital case management, system interoperability, and tissue stewardship.
4
Digital pathology can enable remote specialist consultation and distributed case review, helping laboratories share expertise across locations and time zones.
5
Integrating digital pathology, genomics, AI, and clinical information can support pathologists’ judgment, while turnaround time depends on the entire pathway from test order to accessible reporting.
